Carregant...
Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospital
BACKGROUND: Sacubitril/valsartan has been incorporated into guidelines based on the results of the PARADIGM-HF trial, which demonstrated reduced mortality in stable patients with heart failure with reduced ejection fraction (HFrEF). Sacubitril/valsartan is recommended in addition to other HF therapi...
Guardat en:
| Publicat a: | J Community Hosp Intern Med Perspect |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034425/ https://ncbi.nlm.nih.gov/pubmed/32128057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2019.1708638 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|